Abstract:The search for natural biologically active substances having a neuroprotective effect against cerebral ischemia-reperfusion injury is one of the major priorities of modern neuroscience and medicine. Intranasal insulin (INI) exerts a pronounced restorative effect on various neurodegenerative diseases, but the mechanisms of its action and its therapeutic effects in cerebral ischemia have not been well studied, including in type 2 diabetes mellitus (DM2) which increases the risk of cerebrovascular dysfunction. The aim of the work was to study the effect of INI on metabolic parameters and inflammatory factors in male Wistar rats with DM2, exposed to cerebral ischemia, as compared to nondiabetic animals. DM2 was induced by a combination of high-fat diet and low-dose (25 mg/kg) streptozotocin administration. Cerebral ischemia was studied in a rat model of global forebrain ischemia-reperfusion (IR) injury induced by occlusion of both common carotid arteries, followed by a 7-day reperfusion. Two h after the end of ischemic exposure, the rats were treated with INI at a dose of 0.5 or 2.0 IU/rat, after which the drug was administered at the same dose, once a day, for the following 7 days. INI was found to prevent body weight loss in both nondiabetic and DM2 IR-exposed rats, while elevating plasma total cholesterol levels and epididymal fat fraction in IR-exposed nondiabetic animals only. In IR-exposed DM2 rats, INI (at both doses used) reduced postprandial plasma levels of glucose and insulin, indicative of improved glucose tolerance, as well as plasma levels of inflammatory factors, C-reactive protein (at a dose of 0.5 IU/rat/day), and tumor necrosis factor-α (at a dose of 2 IU/rat/day), indicative of its anti-inflammatory potential. Thus, a post-IR course treatment with INI improves metabolic parameters and abates inflammatory responses in DM2 rats, which may be in high demand when correcting ischemic stroke in patients with DM2.

Intranasal Insulin Treatment Attenuates Metabolic Distress and Early Brain Injury After Subarachnoid Hemorrhage in Mice

Intranasal Insulin Ameliorates Cerebral Hypometabolism, Neuronal Loss, and Astrogliosis in Streptozotocin-Induced Alzheimer’s Rat Model

Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer’s rat model

Intranasal insulin alleviates cognitive deficits and amyloid pathology in young adult APPswe/PS1dE9 mice.

Potential Application of Intranasal Insulin Delivery for Treatment of Intracerebral Hemorrhage: A Review of The Literature

Intranasal insulin administration may be highly effective in improving cognitive function in mice with cognitive dysfunction by reversing brain insulin resistance

Effect of Intranasal Insulin on Metabolic Parameters and Inflammation Factors in Diabetic Rats Exposed to Cerebral Ischemia-Reperfusion

The Window of Opportunity for Treatment of Focal Cerebral Ischemic Damage with Noninvasive Intranasal Insulin-Like Growth Factor-I in Rats.

Intranasal Wnt-3A Alleviates Neuronal Apoptosis in Early Brain Injury Post Subarachnoid Hemorrhage Via the Regulation of Wnt Target PPAN Mediated by the Moonlighting Role of Aldolase C

Intranasal Insulin Administration to Rats with Forebrain Ischemia and Reperfusion Injury Reduces Autophagy and Apoptosis Intensity in the Hippocampus and Frontal Cortex, a Possible Mechanism of Action

Prospects for the Use of Intranasally Administered Insulin and Insulin-Like Growth Factor-1 in Cerebral Ischemia

Intranasal Insulin Prevents Anesthesia-induced Cognitive Impairments in Aged Mice

Central effects of acute intranasal insulin on neuroimaging, cognitive, and behavioural outcomes: A systematic review

Intranasal Salvinorin A Improves Long-term Neurological Function Via Immunomodulation in a Mouse Ischemic Stroke Model.

Intravenous Administration of Hair Follicle Mesenchymal Stem Cells and Insulin Growth Factor-1 Improves the Neurological Performances of Rats Following Focal Cerebral Ischemia

The combination treatment of hypothermia and intranasal insulin ameliorates the structural and functional changes in a rat model of traumatic brain injury

Non-Invasive Intranasal Insulin-Like Growth Factor-I Reduces Infarct Volume and Improves Neurologic Function in Rats Following Middle Cerebral Artery Occlusion

Effect of intranasal insulin on perioperative cognitive function in older adults: a randomized, placebo-controlled, double-blind clinical trial

Naringenin Reduces Early Brain Injury in Subarachnoid Hemorrhage (SAH) Mice: the Role of the AMPK/SIRT3 Signaling Pathway

Intranasal Administration of the SUR1 Inhibitor Glibenclamide for the Treatment of Traumatic Brain Injury

Intranasal Delivery of Nerve Growth Factor to Protect the Central Nervous System Against Acute Cerebral Infarction.